VS-5584

Keep an Eye on Geron, Novartis, Cell Therapeutics, and Verastem Today
Motley Fool
Tue, 12/10/13 - 11:36 am
Verastem
Cell Therapeutics
Novartis
Geron
imetelstat
Jakavi
myelofibrosis
tosedostat
AML
VS-5584
Verastem: An Attractive Long-Term Investment In The Cancer Stem Cell Space
Seeking Alpha
Tue, 09/17/13 - 09:54 am
stem cells
cancer
Verastem
VS-4718
Defactinib
VS-5584